Title : Efficacy of rasagiline and selegiline in Parkinson's disease: a head-to-head 3-year retrospective case-control study.

Pub. Date : 2017 Jun

PMID : 28550482






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Monoamine oxidase type B (MAO-B) inhibitors, such as selegiline and rasagiline, can be used as monotherapy or adjuvant therapy to levodopa in Parkinson"s disease (PD). Selegiline monoamine oxidase B Homo sapiens
2 Monoamine oxidase type B (MAO-B) inhibitors, such as selegiline and rasagiline, can be used as monotherapy or adjuvant therapy to levodopa in Parkinson"s disease (PD). Selegiline monoamine oxidase B Homo sapiens